Results 251 to 260 of about 1,741,500 (304)
Cellular therapy for traumatic brain injury in adults: a meta-analysis of controlled clinical trials. [PDF]
Arch Med SciAlizada M +6 more
europepmc +1 more source
Obesity and Outcomes in Adoptive Cellular Therapy in Solid Tumors.
JAMA Netw OpenTao DL +7 more
europepmc +1 more source
CRISPR/Cas9-mediated PD-1 attenuation enhances tumor infiltrating lymphocyte-based adoptive cellular therapy in humanized-PDX model of hepatocellular carcinoma. [PDF]
Transl OncolGe W +13 more
europepmc +1 more source
The intestinal microbiota and cellular therapy: implications for impact and mechanisms.
BloodXie J, Smith M.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hematological Oncology, 2023
Abstract CD19‐directed chimeric antigen receptor (CAR) T‐cell therapy has had a dramatic impact on the natural history and survival of patients with high‐risk B‐cell non‐Hodgkin lymphoma. Accompanying this success has been the development of new fields of medicine and investigation into toxicity risks and mitigation therapies ...
Anna Sureda +13 more
openaire +3 more sources
Abstract CD19‐directed chimeric antigen receptor (CAR) T‐cell therapy has had a dramatic impact on the natural history and survival of patients with high‐risk B‐cell non‐Hodgkin lymphoma. Accompanying this success has been the development of new fields of medicine and investigation into toxicity risks and mitigation therapies ...
Anna Sureda +13 more
openaire +3 more sources
Obstetrics and Gynecology Clinics of North America, 1997
From a clinical perspective, prenatal transplantation has tremendous potential to broaden the current indications for reconstitution therapy and to offer a safe, efficacious, and cost-effective alternative to conventional postnatal BMT for many congenital hematopoietic diseases.
A W, Flake, E D, Zanjani
openaire +3 more sources
From a clinical perspective, prenatal transplantation has tremendous potential to broaden the current indications for reconstitution therapy and to offer a safe, efficacious, and cost-effective alternative to conventional postnatal BMT for many congenital hematopoietic diseases.
A W, Flake, E D, Zanjani
openaire +3 more sources
Transplantation Proceedings, 2005
Cellular genetic therapy is the ultimate frontier for those pathologies that are consequent to a specific nonfunctional cellular type. A viable cure for there kinds of diseases is the replacement of sick cells with healthy ones, which can be obtained from the same patient or a different donor.
Del Vecchio, F +4 more
openaire +4 more sources
Cellular genetic therapy is the ultimate frontier for those pathologies that are consequent to a specific nonfunctional cellular type. A viable cure for there kinds of diseases is the replacement of sick cells with healthy ones, which can be obtained from the same patient or a different donor.
Del Vecchio, F +4 more
openaire +4 more sources
Therapeutische Umschau. Revue therapeutique, 2020
Cellular therapies Abstract. Transfusion medicine and allogeneic stem cell transplantation are well known and established cellular therapies in hematology. Since decades many efforts have been made, in order to re-program the patient's own immune system in order to clear malignancies. A breakthrough was achieved with the manufacturing and optimizing of
Andreas, Holbro +6 more
openaire +3 more sources
Cellular therapies Abstract. Transfusion medicine and allogeneic stem cell transplantation are well known and established cellular therapies in hematology. Since decades many efforts have been made, in order to re-program the patient's own immune system in order to clear malignancies. A breakthrough was achieved with the manufacturing and optimizing of
Andreas, Holbro +6 more
openaire +3 more sources
Current Opinion in Oncology, 1993
Attempts to treat cancer by stimulation of cell-mediated responses in the host (active immunotherapy) or by adoptive transfer of lymphocytes remain the major areas of research in biologic therapy for cancer. Focus in adoptive immunotherapy has swung decisively from transfer of lymphokine-activated killer cells together with interleukin-2 to transfer of
openaire +2 more sources
Attempts to treat cancer by stimulation of cell-mediated responses in the host (active immunotherapy) or by adoptive transfer of lymphocytes remain the major areas of research in biologic therapy for cancer. Focus in adoptive immunotherapy has swung decisively from transfer of lymphokine-activated killer cells together with interleukin-2 to transfer of
openaire +2 more sources